Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy?-Reference-Cited by-同舟云学术

Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy?

Published:2013-02 Issue:1 Volume:138 Page:273-279
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Narod Steven A.,Metcalfe Kelly,Lynch Henry T.,Ghadirian Parviz,Robidoux Andre,Tung Nadine,Gaughan Elizabeth,Kim-Sing Charmaine,Olopade Olufunmilayo I.,Foulkes William D.,Robson Mark,Offit Kenneth,Jakubowska Ania,Byrski Tomasz,Huzarski Tomasz,Sun Ping,Lubinski Jan

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-013-2429-x.pdf

Reference15 articles.

1. Senn HJ, Thürlimann B, Goldhirsch A, Wood WC, Gelber RD, Coates AS (2003) Comments on the St. Gallen Consensus 2003 on the primary therapy of early breast cancer. Breast 12:569–582

2. Bharat A, Aft RL, Gao F, Margenthaler JA (2009) Patient and tumor characteristics associated with increased mortality in young women (< or =40 years) with breast cancer. J Surg Oncol 100:248–251

3. Narod SA, Foulkes WD (2004) BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 4:665–676

4. Foulkes WD, Metcalfe K, Hanna W, Lynch HT, Ghadirian P, Tung N et al (2003) Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma. Cancer 98:1569–1577

5. Rennert G, Bisland-Naggan S, Barnett-Griness O, Bar-Joseph N, Zhang S, Rennert HS et al (2007) Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations. N Engl J Med 357:115–123

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic treatment of breast cancer in young patients with a germline mutation in the BRCA1 and BRCA2 genes;Onkologie;2023-06-16

2. Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study;Breast Cancer Research and Treatment;2022-05-04

3. Clinical outcomes and Oncotype DX Breast Recurrence Score® in early‐stage BRCA ‐associated hormone receptor‐positive breast cancer;Cancer Medicine;2022-02-06

4. Management of Hereditary Breast Cancer: An Overview;Breast Cancer;2022

5. OncotypeDX© Recurrence Score in BRCA mutation carriers: a systematic review and meta-analysis;European Journal of Cancer;2021-09